Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03721926 · ClinicalTrials.gov registry record · NA
A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer
A NA study of Other Cancer, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 1
- Study location
NCT03721926 is a NA study of Other Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 91 participants, below the 3,249-participant average among 5 other Other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03721926, a NA study of Other Cancer, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to develop a geriatric oncology collaborative care intervention to enhance the quality of life, symptom burden, and functional outcomes of older adults with advanced gastrointestinal (GI) and genitourinary (GU) cancers.
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER Geriatric Oncology Collaborative Care
Study Locations (1)
Massachusetts
- Massachusetts General Hospital Cancer Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2019-02-14 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03721926
The ClinicalTrials.gov registry entry for NCT03721926 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,249-participant average among 5 other Other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Other Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT03721926 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03721926 about?
NCT03721926 is a clinical study titled "A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer". The purpose of this research study is to develop a geriatric oncology collaborative care intervention to enhance the quality of life, symptom burden, and functional outcomes of older adults with advanced gastrointestinal (GI) and genitourinary (GU) cancers.
What is the current status of trial NCT03721926?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2019-02-14. Estimated completion is 2022-03-31.
What conditions does trial NCT03721926 study?
This clinical trial studies the following conditions: Other Cancer.
What interventions are being tested in trial NCT03721926?
The interventions under investigation include: Usual Care (OTHER), Geriatric Oncology Collaborative Care (OTHER).
Who is sponsoring clinical trial NCT03721926?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03721926 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Other Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)
RECRUITING · NA
-
A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live CoActive Exercise Coaching and Personalized Digital Application on Cancer Survivors' Quality of Life
ACTIVE NOT RECRUITING · NA
-
Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly
COMPLETED · NA
-
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
RECRUITING
-
Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.